Weekly Newsletter Signup | Vendors, CIO Viewpoint, CXO Insights
pharmatechoutlook

Weekly Brief

Subscribe

Weekly Brief

Thursday, March 19,2020

Feature of the Week

Improving drug discovery has become a big challenge for the pharma industry. Therefore, scientists have developed collapsible basket technology for enhancing drug discovery and customized medicine.  Read more
With deadly diseases like coronavirus, cholera, spreading, it has become vital to discover vaccines or technologies for diagnosing it. Recently scientists have discovered a device that is capable of detecting viruses.  Read more
Artificial Intelligence has already proven to be a boon for several industries, and the pharmaceutical industry is no exception to that.  Read more

CIO Viewpoint

By Riccardo Altura, CIO, Centro Medico Santagostino  
Every patient must have a complete vision through his data, who is using it and why, and the healthcare providers must work to protect that data, especially when working with doctors and clinical staff.  Read more
By Colin Boatwright, CIO, Ironshore Pharmaceuticals Inc  
Small, iterative upgrades will keep you current and avoid the situation many are in today with systems that were left on auto pilot, but have nowhere left to go.  Read more

Featured Vendors

By Dr. Martina Diminić Smetiško, Managing Director  
Marti Farm, a company based out of Zagreb, Croatia, is a contract research organization supporting the needs of the pharmaceutical, biotechnology, medical devices, food supplement and cosmetics industries across a variety of core services areas....  Read more
By Anders Mortin, MSc, Co-founder and DirectorMagnus Värendh, MSc, Co-founder and Managing Director  
TriTiCon is a clinical trial management provider that offers strategic consultancy expertise in the area of clinical data handling, TriTiCon is dedicated to helping pharmaceutical and biotech companies, CROs, start-ups and tech providers navigate...  Read more
By Noelle Callizot, CSO  
Neuro-Sys is a drug development and services company focused on neurodegenerative diseases. The company has developed specific pre-clinical models of neurological diseases to accurately determine the lead compounds’ pharmacological profiling and...  Read more

CXO Insights

By Neil Aubuchon, VP-Global Marketing, Santen  
Randomized, placebo-controlled Phase III clinical trials (or RCT’s for short) traditionally...  Read more
By Kevin Dawson, VP, Information Services, Los Angeles Biomedical Research Institute  
IT executives are expected to be business leaders responsible for the information services function...  Read more